EP1274862A4 - Regulation eines gens welches durch oxidierte lipide in menschlichen arterien wandzellen induziert wird - Google Patents
Regulation eines gens welches durch oxidierte lipide in menschlichen arterien wandzellen induziert wirdInfo
- Publication number
- EP1274862A4 EP1274862A4 EP01923022A EP01923022A EP1274862A4 EP 1274862 A4 EP1274862 A4 EP 1274862A4 EP 01923022 A EP01923022 A EP 01923022A EP 01923022 A EP01923022 A EP 01923022A EP 1274862 A4 EP1274862 A4 EP 1274862A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- oxidised
- phospholipid
- mammal
- atherosclerosis
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US541468 | 1983-10-13 | ||
US53956900A | 2000-03-31 | 2000-03-31 | |
US539569 | 2000-03-31 | ||
US09/541,468 US6596544B1 (en) | 2000-03-31 | 2000-03-31 | Functional assay of high-density lipoprotein |
PCT/US2001/010590 WO2001075168A1 (en) | 2000-03-31 | 2001-03-29 | Control of a gene induced by oxidized lipids in human artery wall cells |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1274862A1 EP1274862A1 (de) | 2003-01-15 |
EP1274862A4 true EP1274862A4 (de) | 2005-06-22 |
Family
ID=27066136
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01923022A Withdrawn EP1274862A4 (de) | 2000-03-31 | 2001-03-29 | Regulation eines gens welches durch oxidierte lipide in menschlichen arterien wandzellen induziert wird |
EP01923023A Expired - Lifetime EP1272666B1 (de) | 2000-03-31 | 2001-03-29 | Funktionaler nachweis von lipoprotein mit hoher dichte |
EP05022081A Withdrawn EP1650312A3 (de) | 2000-03-31 | 2001-03-29 | Funktionaler Nachweis von Lipoprotein mit hoher Dichte |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01923023A Expired - Lifetime EP1272666B1 (de) | 2000-03-31 | 2001-03-29 | Funktionaler nachweis von lipoprotein mit hoher dichte |
EP05022081A Withdrawn EP1650312A3 (de) | 2000-03-31 | 2001-03-29 | Funktionaler Nachweis von Lipoprotein mit hoher Dichte |
Country Status (9)
Country | Link |
---|---|
EP (3) | EP1274862A4 (de) |
JP (2) | JP4675539B2 (de) |
AT (1) | ATE306563T1 (de) |
AU (3) | AU4976101A (de) |
CA (2) | CA2404350A1 (de) |
DE (1) | DE60113976T2 (de) |
DK (1) | DK1272666T3 (de) |
ES (1) | ES2250378T3 (de) |
WO (2) | WO2001075168A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6838452B2 (en) * | 2000-11-24 | 2005-01-04 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
US7807847B2 (en) | 2004-07-09 | 2010-10-05 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
GB0421176D0 (en) * | 2004-09-23 | 2004-10-27 | Poston Robin | Treatment of atherosclerosis |
EP2218736A1 (de) | 2004-10-15 | 2010-08-18 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Implantate, die mit amphipathischen helikalen Peptiden beschichtet sind, die mehrere Domaenen enthalten, und Verfahren zu ihrer Verwendung |
AU2006274477B2 (en) * | 2005-07-27 | 2011-05-12 | Technische Universitat Graz | Oxidised phospholipids comprising a fluorophore moiety and use in the determination of the presence of enzymes having antiatherogenetic activity |
AU2007284801A1 (en) | 2006-08-08 | 2008-02-21 | The Regents Of The University Of Californina | Salicylanilides enhance oral delivery of therapeutic peptides |
US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
DK2682400T5 (da) | 2007-08-28 | 2017-11-27 | Uab Research Foundation | Syntetiske apolipoprotein E-efterlignende polypeptider og fremgangsmåder til anvendelse |
RU2532546C2 (ru) | 2008-11-06 | 2014-11-10 | Васкьюлар Байодженикс Лтд. | Окисленные соединения липидов и их применение |
AU2015298263B2 (en) | 2014-07-31 | 2020-05-14 | Anji Pharmaceuticals, Inc. | ApoE mimetic peptides and higher potency to clear plasma cholesterol |
US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
WO2016084023A1 (en) | 2014-11-26 | 2016-06-02 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
US10905736B2 (en) | 2016-09-28 | 2021-02-02 | The Regents Of The University Of California | Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism |
JP7084590B2 (ja) * | 2016-10-31 | 2022-06-15 | 国立大学法人大阪大学 | 脂質異常症治療が必要な被検者の選別方法及び選別用試薬 |
WO2018165574A1 (en) * | 2017-03-10 | 2018-09-13 | The Regents Of The University Of California | Method for diagnosing risk for inflammatory disease through glycan profiling |
WO2021172380A1 (ja) * | 2020-02-25 | 2021-09-02 | 株式会社Lsiメディエンス | 核酸医薬品等の分析方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020897A1 (en) * | 1996-11-15 | 1998-05-22 | President And Fellows Of Harvard College | Modulation of map kinase phosphatase 1 (mkp-1) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5820932Y2 (ja) * | 1979-01-27 | 1983-05-02 | 財団法人杉山産業化学研究所 | 過酸化脂質測定のためのtba試験紙 |
JPS56117798A (en) * | 1980-02-21 | 1981-09-16 | Toyo Jozo Co Ltd | Kit for measuring lipoid peroxide |
JPS60133368A (ja) * | 1983-12-19 | 1985-07-16 | Dai Ichi Pure Chem Co Ltd | 免疫測定方法 |
JPH01231897A (ja) * | 1988-03-11 | 1989-09-18 | Fuji Photo Film Co Ltd | 乾式グルコース分析要素 |
US5135716A (en) * | 1989-07-12 | 1992-08-04 | Kingston Diagnostics, L.P. | Direct measurement of HDL cholesterol via dry chemistry strips |
WO1994023302A1 (en) * | 1993-04-07 | 1994-10-13 | The Australian National University | Immunological assay of oxidatively modified human low density lipoproteins in plasma |
RU94044169A (ru) * | 1994-12-16 | 1996-10-20 | И.А. Кочетов | Многослойный аналитический элемент |
US5958714A (en) * | 1996-10-02 | 1999-09-28 | Safety Associates, Inc. | Test kits for determining at least two specific analytes in foods and other complex matrices |
JP3428853B2 (ja) * | 1997-04-02 | 2003-07-22 | 東北電子産業株式会社 | 液体試料の抗酸化力を測定するための方法および装置 |
WO1998059248A1 (en) * | 1997-06-20 | 1998-12-30 | Leuven Research & Development Vzw | Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
US5989803A (en) * | 1997-09-05 | 1999-11-23 | The Trustees Of Columbia University In The City Of New York | Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase |
-
2001
- 2001-03-29 EP EP01923022A patent/EP1274862A4/de not_active Withdrawn
- 2001-03-29 JP JP2001573042A patent/JP4675539B2/ja not_active Expired - Fee Related
- 2001-03-29 AT AT01923023T patent/ATE306563T1/de active
- 2001-03-29 AU AU4976101A patent/AU4976101A/xx not_active Withdrawn
- 2001-03-29 EP EP01923023A patent/EP1272666B1/de not_active Expired - Lifetime
- 2001-03-29 DK DK01923023T patent/DK1272666T3/da active
- 2001-03-29 ES ES01923023T patent/ES2250378T3/es not_active Expired - Lifetime
- 2001-03-29 WO PCT/US2001/010590 patent/WO2001075168A1/en active Application Filing
- 2001-03-29 WO PCT/US2001/010592 patent/WO2001075170A1/en active IP Right Grant
- 2001-03-29 JP JP2001573040A patent/JP2003529375A/ja not_active Withdrawn
- 2001-03-29 AU AU2001249762A patent/AU2001249762B2/en not_active Ceased
- 2001-03-29 DE DE60113976T patent/DE60113976T2/de not_active Expired - Lifetime
- 2001-03-29 CA CA002404350A patent/CA2404350A1/en not_active Abandoned
- 2001-03-29 EP EP05022081A patent/EP1650312A3/de not_active Withdrawn
- 2001-03-29 CA CA2404000A patent/CA2404000C/en not_active Expired - Fee Related
- 2001-03-29 AU AU4976201A patent/AU4976201A/xx active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020897A1 (en) * | 1996-11-15 | 1998-05-22 | President And Fellows Of Harvard College | Modulation of map kinase phosphatase 1 (mkp-1) |
Non-Patent Citations (6)
Title |
---|
DUFF JENNIFER L ET AL: "Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells: Effect of actinomycin D and antisense oligonucleotides", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 13, 1995, pages 7161 - 7166, XP002325494, ISSN: 0021-9258 * |
HUANG Y ET AL: "Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages.", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. JUL 1999, vol. 19, no. 7, July 1999 (1999-07-01), pages 1600 - 1607, XP002325496, ISSN: 1079-5642 * |
LAI K ET AL: "MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE-1 IN RAT ARTERIAL SMOOTH MUSCLE CELL PROLIFERATION", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 98, no. 7, October 1996 (1996-10-01), pages 1560 - 1567, XP002058893, ISSN: 0021-9738 * |
METZLER B ET AL: "Induction of mitogen-activated protein kinase phosphatase-1 by arachidonic acid in vascular smooth muscle cells.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 11 DEC 1998, vol. 273, no. 50, 11 December 1998 (1998-12-11), pages 33320 - 33326, XP002325495, ISSN: 0021-9258 * |
REDDY SRINIVASA ET AL: "Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 20, 18 May 2001 (2001-05-18), pages 17030 - 17035, XP002325497, ISSN: 0021-9258 * |
SUBBANAGOUNDER ET AL.: "EVIDENCE THAT PHOSPHOLIPID OXIDATION PRODUCTS AND/OR PLATELET-ACTIVATING FACTOR PLAY AN IMPORTANT ROLE IN EARLY ATHEROGENESIS IN VITRO AND IN VIVO INHIBITION BY WEB 2086", CIRCULATION RESEARCH, GRUNE AND STRATTON, BALTIMORE, US, no. 85, 20 August 1999 (1999-08-20), pages 311 - 318, XP002951988, ISSN: 0009-7330 * |
Also Published As
Publication number | Publication date |
---|---|
EP1650312A2 (de) | 2006-04-26 |
EP1272666B1 (de) | 2005-10-12 |
DE60113976T2 (de) | 2006-07-27 |
AU4976201A (en) | 2001-10-15 |
JP2003529375A (ja) | 2003-10-07 |
AU4976101A (en) | 2001-10-15 |
AU2001249762B2 (en) | 2006-03-30 |
ES2250378T3 (es) | 2006-04-16 |
DK1272666T3 (da) | 2006-02-27 |
EP1272666A4 (de) | 2004-09-22 |
JP2003529775A (ja) | 2003-10-07 |
CA2404000A1 (en) | 2001-10-11 |
JP4675539B2 (ja) | 2011-04-27 |
ATE306563T1 (de) | 2005-10-15 |
DE60113976D1 (de) | 2006-02-23 |
EP1272666A1 (de) | 2003-01-08 |
EP1274862A1 (de) | 2003-01-15 |
CA2404000C (en) | 2010-07-27 |
CA2404350A1 (en) | 2001-10-11 |
EP1650312A3 (de) | 2006-05-17 |
WO2001075170A1 (en) | 2001-10-11 |
WO2001075168A1 (en) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4976101A (en) | Control of a gene induced by oxidized lipids in human artery wall cells | |
CN101078719B (zh) | 测量仪操作方法及测量仪 | |
GR3035274T3 (en) | Method of quantitative analysis of cholesterol | |
GB2365526B (en) | Assay apparatus for measuring the amount of an analyte in a biological or environmental sample | |
DK1269173T3 (da) | Glucosesensor med hurtigt respons | |
DK0659275T3 (da) | Analytisk testapparat med indbygget negativ og positiv kontrol | |
NO176293C (no) | Metode for å bestemme en ligand i en pröve ved bruk av en optisk bölgeleder og en anordning for utförelse av metoden | |
BRPI0607912A2 (pt) | ensaio para determinar a presença, ausência ou saúde de uma célula, analito, ácido nucléico ou microorganismo em uma amostra, sonda, métodos para selecionar um analito que se ligue a um composto, para determinar se um ácido nucléico de interesse interage com uma proteína de interesse em uma célula ou uma amostra invitro, e para determinar a presença ou ausência de um ou mais compostos alvo em uma amostra, kit para manchar células, analitos, ácidos nucléicos ou microorganismos em uma amostra, e, composto" | |
WO2004000884A3 (fr) | Compositions et methodes pour le dosage de l'apo b48 et de l'apo b100 | |
DE68913086T2 (de) | Qualitativer Enzymtest zur visuellen Auswertung. | |
PT975974E (pt) | Ensaio utilizando particulas magneticas | |
EP1424558A4 (de) | Reagenz zum testen von laminin-5-antigen in einer biologischen probe und testverfahren | |
DE59812075D1 (de) | Verwendung von Annexinen als Lupus Antikoagulans Kontrolle oder Standard in Gerinnungstesten | |
WO1998059068A1 (fr) | Procede servant a analyser des specimens biologiques afin de rechercher des substances contenues dans leurs constituants et reactif utilise dans ce procede | |
TR200402619T4 (tr) | İdrardaki redoks durumunun tespiti için kit ve yöntem. | |
DE69331585D1 (de) | Monoklonaler antikörper spezifisch für das fk-506-bindende protein, methode zur bestimmung des gehaltes an fk-506-bindendem protein in einer probe und reagenzsatz dafür | |
GB2237108A (en) | Assay for enzyme activity | |
AU3571901A (en) | Electrochemical method for detecting nucleic acids | |
DK0790494T3 (da) | Flerlaget testmiddel | |
Cominacini et al. | The need for a ‘free radical initiative’ | |
Glick | The future of clinical microchemical analysis. | |
JPS5564800A (en) | Method and reagent for determination of acyl coenzyme a | |
Feltus et al. | Detection of biotin in individual sea urchin oocytes using a bioluminescence binding assay | |
Singh et al. | Construction of a Micropycnometer for Determination of Density and Specific Gravity of Liquids and Solutions | |
Donaghy | Autonomous Mathematical Models: Constructing Theories of Metabolic Control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20021001 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050506 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090328 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1052373 Country of ref document: HK |